Serum level of IP-10 increases predictive value of IL28B polymorphisms for spontaneous clearance of acute HCV infection

Gastroenterology

Volumn 142, Issue 1, 2012, Pages

  Beinhardt, Sandra ^a   Aberle, Judith H ^a   Strasser, Michael ^b   Duliclakovic, Emina ^c   Maieron, Andreas ^d   Kreil, Anna ^e   Rutter, Karoline ^a   Staettermayer, Albert F ^a   Datz, Christian ^f   Scherzer, Thomas M ^a   Strassl, Robert ^a   Bischof, Martin ^g   Stauber, Rudolf ^h   Bodlaj, Gerd ^i,j   Laferl, Hermann ^k   Holzmann, Heidemarie ^a   Steindlmunda, Petra ^a   Ferenci, Peter ^a   Hofer, Harald ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b PARACELSUS MEDICAL UNIVERSITY   (Austria)

^c WILHELMINEN HOSPITAL   (Austria)

^d Hospital of Elisabethinen   (Austria)

^e Otto Wagner Spital   (Austria)

^f Hospital Oberndorf   (Austria)

^g KRANKENANSTALT RUDOLFSTIFTUNG   (Austria)

^h Department of Gastroenterology ^*  (Austria)

ⁱ MEDICAL UNIVERSITY OF GRAZ   (Austria)

^j KEPLER UNIVERSITY HOSPITAL   (Austria)

^k KAISER FRANZ JOSEF HOSPITAL   (Austria)

more..

Author keywords

Clinical Trial; CXC L10; Prognostic Factors; ROC Analysis

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; GAMMA INTERFERON INDUCIBLE PROTEIN 10; INTERLEUKIN 28B;

ACUTE HEPATITIS; ACUTE HEPATITIS C; ADULT; AGE DISTRIBUTION; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BILIRUBIN BLOOD LEVEL; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE COURSE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE FREQUENCY; GENOTYPE; HEPATITIS C; HETEROZYGOTE; HUMAN; JAUNDICE; MAJOR CLINICAL STUDY; MALE; PREDICTIVE VALUE; PRIORITY JOURNAL; PROGNOSIS; REAL TIME POLYMERASE CHAIN REACTION; RECEIVER OPERATING CHARACTERISTIC; SEX RATIO; SINGLE NUCLEOTIDE POLYMORPHISM; TREATMENT OUTCOME; VIRAL CLEARANCE; VIREMIA; VIRUS DETECTION;

EID: 83755169636     PISSN: 00165085     EISSN: 15280012     Source Type: Journal    
DOI: 10.1053/j.gastro.2011.09.039     Document Type: Article

References (27)

1. H. Hofer, T. Watkins-Riedel, O. Janata Spontaneous viral clearance in patients with acute hepatitis C can be predicted by repeated measurements of serum viral load Hepatology 37 2003 60 64
2. J.T. Gerlach, H.M. Diepolder, R. Zachoval Acute hepatitis C: high rate of both spontaneous and treatment-induced viral clearance Gastroenterology 125 2003 80 88
3. T. Santantonio, J. Wiegand, J.T. Gerlach Acute hepatitis C: current status and remaining challenges J Hepatol 49 2008 625 633
4. J.H. Aberle, E. Formann, P. Steindl-Munda Prospective study of viral clearance and CD4(+) T-cell response in acute hepatitis C primary infection and reinfection J Clin Virol 36 2006 24 31
5. R. Thimme, D. Oldach, K.M. Chang Determinants of viral clearance and persistence during acute hepatitis C virus infection J Exp Med 194 2001 1395 1406
6. H.L. Tillmann, A.J. Thompson, K. Patel A polymorphism near IL28B is associated with spontaneous clearance of acute hepatitis C virus and jaundice Gastroenterology 139 2010 1586 1592
7. D.L. Thomas, C.L. Thio, M.P. Martin Genetic variation in IL28B and spontaneous clearance of hepatitis C virus Nature 461 2009 798 801
8. J. Grebely, K. Peoumenos, M. Hellard Potential role for interleukin-28B genotype in treatment decision-making in recent hepatitis c virus infection Hepatology 52 2010 1216 1224
9. M. Cornberg, K. Deterding, M.P. Manns Present and future therapy for hepatitis C virus Expert Rev Anti Infect Ther 4 2006 781 793
10. E. Jaeckel, M. Cornberg, H. Wedemeyer Treatment of acute hepatitis C with interferon alfa-2b N Engl J Med 345 2001 1452 1457
11. G. Askarieh, A. Alsiö, P. Pugnale Systemic and intrahepatic interferon-gamma-inducible protein 10 kDA predicts the first-phase decline in hepatitis C virus RNA and overall viral response to therapy in chronic hepatitis C Hepatology 51 2010 1523 1530
12. M. Diago, G. Castellano, J. García-Samaniego Association of pretreatment serum interferon gamma inducible protein 10 levels with sustained virological response to peginterferon plus ribavirin therapy in genotype 1 infected patients with chronic hepatitis C Gut 55 2006 374 379
13. M. Lagging, A.I. Romero, J. Westin (DITTO-HCV Study Group) IP-10 predicts viral response and therapeutic outcome in difficult-to-treat patients with HCV genotype 1 infection Hepatology 44 2006 1617 1625
14. T. Reiberger, J.H. Aberle, M. Kundi IP-10 correlates with hepatitis C viral load, hepatic inflammation and fibrosis and predicts hepatitis C virus relapse or non-response in HIV-HCV coinfection Antivir Ther 13 2008 969 976
15. J.M. Darling, J. Aerssens, G. Fanning Quantitation of pretreatment serum IP-10 improves the predictive value of an IL28B gene polymorphism for hepatitis C treatment response Hepatology 53 2011 14 22
16. H. Nomura, S. Sou, H. Tanimoto Short-term interferon-alpha therapy for acute hepatitis C: a randomized controlled trial Hepatology 39 2004 1213 1219
17. J. Delwaide, N. Bourgeois, C. Gerard Treatment of acute hepatitis C with interferon alpha-2b: early initiation of treatment is the most effective predictive factor of sustained viral response Aliment Pharmacol Ther 20 2004 15 22
18. K.E. Corey, J. Mendez-Navarro, E.C. Gorospe Early treatment improves outcomes in acute hepatitis C virus infection: a meta-analysis J Viral Hepat 17 2010 201 207
19. S.M. Kamal, A.E. Fouly, R.R. Kamel Peginterferon alfa-2b therapy in acute hepatitis C: impact of onset of therapy on sustained virologic response Gastroenterology 130 2006 632 638
20. T. Santantonio, M. Fasano, E. Sinisi Efficacy of a 24-week course of PEG-interferon alpha-2b monotherapy in patients with acute hepatitis C after failure of spontaneous clearance J Hepatol 42 2005 329 333
21. A.F. Stttermayer, R. Stauber, H. Hofer Impact of IL28B genotype on the early and sustained virologic response in treatment-naive patients with chronic hepatitis C Clin Gastroenterol Hepatol 9 2011 344 350
22. Y. Tanaka, N. Nishida, M. Sugiyama Genome-wide association of IL28B with response to pegylated interferon-alpha and ribavirin therapy for chronic hepatitis C Nat Genet 41 2009 399 401
23. A. Balagopal, D.L. Thomas, C.L. Thio IL28B and the control of hepatitis C virus infection Gastroenterology 139 2010 1865 1876
24. M. Honda, A. Sakai, T. Yamashita Hepatic ISG expression is associated with genetic vairation in interleukin28B and the outcome of IFN therapy for chronic hepatitis C Gastroenterology 139 2010 499 509
25. A.J. Thompson, A.J. Muir, M.S. Sulkowski Interleukin-28B polymorphism improves viral kinetics and is the strongest pretreatment predictor of sustained virologic response in genotype 1 hepatitis C virus Gastroenterology 139 2010 120 129
26. D. Ge, J. Fellay, A.J. Thompson Genetic variation in IL28B predicts hepatitis C treatment induced viral clearance Nature 461 2009 399 401
27. J.W. Mosley, E.A. Operskalski, L.H. Tobler The course of hepatitis C viraemia in transfusion recipients prior to availability of antiviral therapy J Viral Hepat 15 2008 120 128